But will the ‘Ant-Man and the Wasp: Quantumania’ opening weekend box office compare to the rest of the MCU? Check out this chart.
: Ohio train derailment’s chemical contamination: Your questions answered
East Palestine, Ohio, and the wider U.S. want to know: Is a contaminated Ohio River carrying chemicals elsewhere? Are animals dying? What’s the EPA saying?
Market Extra: Will recession slam the stock market? Here are 3 ‘landing’ scenarios as Fed keeps up the inflation fight.
Here’s what investors need to know as economists, investors and policy makers debate whether the Federal Reserve can avoid tipping the economy into a recession.
Deep Dive: 14 dividend stocks that rose 100% or more in 5 years as the payouts doubled
These dividend stocks have helped investors follow a ‘growth, then income’ strategy
Market Extra: Stock-market bulls defiant as bond market surrenders to Fed. Here’s what to watch.
The U.S. bond market blinked in a staring contest with the Federal Reserve over future interest rate hikes. The stock market, not so much.
Deep Dive: 10 dividend stocks with yields as high as 6.5% from a value manager with a strong track record
John Buckingham of The Prudent Speculator offers stock picks for investors who share his “passion for value investing.”
In One Chart: Crypto industry’s annual spending on Washington lobbying more than doubles
The cryptocurrency industry sharply increased its annual spending on Washington lobbying last year, shelling out more than it ever has before — $21.55 million.
Mutual Funds Weekly: These money and investing tips can hold up your portfolio if the market melts down
Money and investing stories popular with MarketWatch readers over the past week.
The New York Post: Senior ISIS leader Hamza al-Homsi killed in U.S.-led raid late Thursday in Syria, says U.S. Central Command
Four U.S. military personnel and working dog said to have been wounded when the Islamic State leader detonated an explosive vest. They are receiving treatment in Iraq.
The Wall Street Journal: Abbott Laboratories under SEC and FTC investigation over baby-formula business
The Securities and Exchange Commission and Federal Trade Commission are investigating Abbott Laboratories’ baby-formula business, the company said.